103 US Marines Discharged For Refusing Covid Vaccine
EXCLUSIVE: House Republicans Demand Answers On Apple’s Censorship Policies In China
- EXCLUSIVE: House Republicans Demand Answers On Apple’s Censorship Policies In China
- Taking a Cue From China, Facebook Censors Chinese Whistleblower on COVID’s Origins
- Breaking: after nearly two years, the Uyghur Forced Labor Prevention Act is finally passed and set to be signed into law!
- Commerce Acts to Deter Misuse of Biotechnology, Other U.S. Technologies by the People’s Republic of China to Support Surveillance and Military Modernization that Threaten National Security
- Reuters confirmed that the United States will impose sanctions on a large number of CCP biotech companies and share prices of a large number of biotech companies dropped significantly. ..
- The further promotion of helding Chinese Communist Party accountable to covid19 by the Fox Tucker program is of great significance; after the literary and arts conference, Junke Ho, on behalf of Jinpin Xi, took the stage to clean up the cultural team.
- "Chinese aggression from the Himalayan frontier w/ India to the South China Sea to Taiwan to Japan’s Senkaku Islands could spark broader conflict," Hudson's @LTGHRMcMaster tells @PhelimKine
EXCLUSIVE: Chinese army studied aerosol transmission of deadly virus with a 90% fatality rate
（Picture source：thegatewaypundit）
Thegatewaypundit:EXCLUSIVE: Chinese army Studied aerosol transmission of deadly virus with a 90% fatality rate.
Breaking: GemPharmatech Co., Ltd assisted Chinese People's Liberation Army Developing Covid19 By Supplying Humanized Mice
GemPharmatech Co., Ltd ( 江苏集萃药康生物科技股份有限公司, sometimes also referred to as "Jiangsu Jicui Yaokang Biotechnology Co., Ltd.", GPC), to be flotated on Shanghai Securities Exchange, made humanized mice for Chinese People's Liberation Army, according to the Lude Media show made in Chinese.
GemPharmatech Co., Ltd cooperates closely with Nanjing University. It is also a cooperative unit of the The National Resource Center for Mutant Mice of China and China's largest genetically engineered mouse resource bank, Model Animal Research Center of Nanjing University.
In particular, GemPharmatech Co., Ltd has released ACE2 related experimental data on 29 Jan 2020.
As informed in its IPO prospectus, on 21 February 2019, it signed an agreement with Nanjing University-Nanjing Institute of Biomedicine to acquire 2612 mouse strains and intellectual property rights from the latter. On 15 September 2020, Broad, the intellectual property agent related to genome editing technologies such as CRISPR/Cas9 in Harvard and MIT, licensed GPC to use genome editing technology on 1 January 2018. Starting from 1 January 2019, it jointly built a national genetically engineered mouse resource bank with Nanjing University.
Certification: AAALAC certification by the International Laboratory Animal Evaluation and Accreditation Committee (issued in October 2019), registration certificate of the business unit of explosive hazardous chemicals, registration of export animals and non-edible animal products production, processing, and storage enterprises certificate, Biosafety Laboratory Record Certificate, Laboratory Animal Production and Use Permit (both issued on 6 June 2018). 
Chinese banks providing credit to Jiangbei Industrial Group, the lessor of humanized mice facility and plant: ICBC 15.26 billion, Industrial Bank 6.59 billion, Bank of China 5.916 billion, Nanjing Bank 5.124 billion, China CITIC Bank 4.32 billion, etc. 
GemPharmatech's experimental animal production license SCXK (Su) 2018-0008 barrier range (SPF level: mice, rats, new animal room 2nd and 3rd floors, 4000 m2); GemPharmatech's experimental animal use license SYXK (Su) 2018 -0027 Barrier environment (SPF grade: mice, rats, new animal room on 1st floor, 2,000 m2; 1st phase of scientific research building, new laboratory animal room, 300 m2; SPF grade: mice, GF building area 2, 911 m2) .
On 5 December 2019, GPC rented 4240 square meters in the North Building of the Experimental Animal Center, Southern Park, Genetic Resources Research and Development Center of the Chinese Academy of Sciences, for office and production. In January 2019, 18,500 square meters were leased from Nanjing Jiangbei New Area Industrial Investment Group Co., Ltd. at No. 12 Xuefu Road, Jiangbei New District, Nanjing City for office, R&D and production. The lessor issued USD bonds, private placement bonds and corporate bonds in the inter-bank market. It rented no less than 3,200 square meters in Guangdong. The actual controller of Nanjing Jiangbei Industrial Investment Group is the Administrative Committee of Jiangbei New District. The rent-free transaction of GPC to use the assets of government-controlled enterprises is actually a government subsidy. Government subsidies should be recognized at market rental prices in accordance with the government subsidy accounting standard. However, it failed to recognize or disclose it as a government subsidy. There are only deferred income and total government subsidies, and no netting method subsidy in the notes. Therefore, there are material misstatements in the financial statements and prospectus of GPC. Deposits for renting plant for free may have been exempted, if it is collected, the deposit should not exceed 26,400, because the five largest other receivables in 2020 do not include those due from Jiangbei Industrial Investment Group.
Both Zhoushan bat virus skeleton and GemPharmatech, which produces experimental animal mice, are in the eastern theater of the People's Liberation Army（中国人民解放军东部战区）.
Genera Yuejun Liu: In 1999 led troops to take over Macau; In February 2002, the commander of the 42nd Group of the Army; In June 2007, Chief of Staff of Lanzhou Military Region;
Commander of Lanzhou Military Region in October 2012; In January 2016, Commander of the Eastern Theater; Retired in December 2019.
12 Dec 2021 WSJ： MIT’s Research is Helping the Chinese Military
WSJ: Is MIT’s Research Helping the Chinese Military?
My concerns about how Beijing might be using our findings were dismissed as racist and political.
BBC: Hong Kong artists: Should I stay or should I go?
CNBC:Evergrande slides into default while some ratings agencies keep quiet
Vision Times: 7 Ways China Is Destroying Its Own Economy
Breaking：Chinese Company Assisting Chinese People's Liberation Army Developing Covid19 is to be Listed on Shanghai Exchange.
As indicated in the Lude Media's program and other public records, Shanghai Model Organisms Center, Inc (SMOC or 上海南方模式生物科技股份有限公司), an animal model research and development base of Eight Six Three Plan of the Chinese Ministry of Science and Technology, has obtained stock code 688265 from Shanghai Securities Exchange and is to publicly issue 19.4909 million shares on 17 December 2021, accounting for 25% of the total share capital after the issuance. The preliminary price inquiry date is 14 December 2021. The purchase date is 17 December 2021, and the settlement date is 21 December 2021.
Another company GemPharmatech Co., Ltd or 江苏集萃药康生物科技股份有限公司 (sometimes referred as "Jiangsu Jicui Yaokang Biotechnology Co., Ltd."), said to have assisted Chinese People's Liberation Army developing Covid19, is also to be listed on Shanghai Exchange.
On the website of International Mouse Strain Resource website, the two Chinese companies capable of producing humanized mice were found
GemPharmatech Co., Ltd cooperates closely with Nanjing University. It is also a cooperative unit of the The National Resource Center for Mutant Mice of China and China's largest genetically engineered mouse resource bank, Model Animal Research Center of Nanjing University.
In particular, GemPharmatech Co., Ltd has released ACE2 related experimental data on 29 Jan 2020.
Clients of SMOC included the Second Military Medical University in 2014 and 2015, and the Naval Military Medical University in 2017.
From 2018 to 2020, client included the Chinese Academy of Sciences and its affiliated research institutions. Chinese Academy of Sciences and its affiliated research institutions include Wuhan Institute of Virology and Shanghai Institute of Biological Sciences of the Chinese Academy of Sciences. The Shanghai Pasteur Institute belongs to the Shanghai Academy of Biological Sciences of the Chinese Academy of Sciences.
A gene knock-in revenue of 80,000 yuan from the Air Force Military Medical University was recognized in January 2019. Although it was delivered in December 2018, due to the 30-day objection period, revenue was recognized in January 2019. The revenue of humanized mice delivered to the Military Medical Academy on 23 December 2018 of 71,500 yuan, due to the objection period 15 days, was recognized on 6 January 2019. Clients also include the People's Liberation Army 62036 Troop, armed police, etc.
Part of the transaction records (indirect evidence) between SMOC and 62036 Troop of the PLA, other military universities or hospitals. The above records have been signed and sealed by the record producer and the unit.
Recognition of revenue means that the revenue has occurred and is related to this humanized mouse production company. The amount can be reliably measured and confirmed at an appropriate time. At the same time, the revenue comes from the main business activities of the accounting entity, not from stock trading, bond trading, government subsidies and disposal of assets.
It also means that in sales activities with customers, SMOC selling humanized mice is not an agent. Agencies can only recognize agency service revenue, and the agency does not have to bear the risks related to customer defaults on accounts and inventory, and at the same time the company is not in the role of custodian and transporter. Custodian and transporter only recognize revenue arising from storage and transportation fees.
Business types: customized models, standardized models, model breeding and breeding services. Customized model products provide customers with target gene information and strategy suggestions, complete the strategy design and model construction according to the individual needs of customers, and provide to customers genetically modified animal models that can be inherited stably.
Process flow of genetically modified animal model products
Based on random genetically modified model construction process, there are also quality inspection procedures
Model breeding business refers to the use of genetically modified animal models developed and produced or existing genetically modified animal models provided by customers, through natural breeding methods or assisted reproduction breeding methods, to deliver specific genotype model products to customers in a specific cycle.
The Order Production Department is responsible for order production and batch supply of genetically engineered mice, strain establishment and background purification, and reproduction and provision of commonly used animals. The Molecular and Biochemical Research Department is responsible for mouse genotype PCR identification, mouse RNA expression profile analysis, virus and microbial PCR identification, Western Blot, protein interaction analysis, protein nucleic acid interaction analysis, protein expression and small quantity preparation.
It said in its published documents that when delivering animal models, it firstly performs genotype identification and microbial testing on related models, and obtains a gene sequencing report to confirm that the animal model meets the customer's requirements, and delivers the identification method, sequencing results, conclusion report, and animal model to the customer together. After receiving the animal model, the customer issues a receipt to the company. During the objection period, the customer generally needs to further verify the animal model, and issue a confirmation sheet if the animal model is qualified.
The company applied for patents, and the patents are known to the public. Applied patents: a rapid construction method and application of ACE2 humanized mouse model, construction method and application of humanized CD40 genetically modified animal model, etc. Is ACE2 familiar? Li-Meng Yan mentioned it in her first report.
The company is located in Building 2, No. 1438 Jinliu Road, Tinglin Town, Jinshan District, Shanghai. The land use area is 41,155 square meters. But the prospectus is written in cubic meters of volume. It possesses laboratory animal production license, AAALAC certification, pathogenic microorganism laboratory record, OLAW certification and other certificates.
In 2019, it received a government grant of 300,000 yuan for the research of new humanized mouse products, and in 2020 it received a government grant of 400,000 yuan for a new homologous genetically modified mouse model. The largest government grant is Shanghai Zhangjiang Park Administration (2016) 085 Document No. 2016 which gave 20 million yuan for the capacity improvement construction project of Shanghai's model biotechnology public service platform. In 2016, there was another subsidy of 1.22 million for the model biotechnology professional technical service platform.
SMOC's subsidiaries include Shanghai Toshi Property Management Co., Ltd., Shanghai Toshi Biotechnology Co., Ltd., and Guangdong Nanmo Biotechnology Co., Ltd., all of which are 100% holdings.
SMOC leased 5,683.76㎡ in 2 buildings at No.178 Banxia Road, Pudong New District, Shanghai on 21 August 2015, and 329㎡ in 3 buildings at No.178 Banxia Road on 21 February 2017. The 2020 version of the prospectus also listed rooms 401, 403, 405, 406, 410, 412, 414, 415, 416, 417, and 419 of Building 6, Lane 898, Harley Road, leased from 1 July 2018.
IPO prospectus signed and stamped by accountants, lawyers, and management in 2020: Shuping Gu, deputy manager of SMOC’s biological science and technology research department, used to do research in American universities for a long time. He was a physician at the Naval Hospital and the Fourth Military Medical University of Chinese PLA. She has a book Mouse Developmental Biology and Embryo Experimental Methods. The application areas of gene modification are shown in the attached drawings.
It has accumulated more than 5,000 customized models for customers. Severe immunodeficiency mice are more suitable as carriers for xenogeneic cell transplantation. Atg5 gene is a key protein in the process of autophagy. This model mouse can be used to specifically knock out Atg5 gene in specific tissues or cells.
The production license and use license of Laboratory Animals obtained by the SMOC were effective from 31 August 2017. Broad, the patent agency of Massachusetts Institute of Technology and Harvard, began to license gene editing technology (including a series of patents related to CRISPR/Cas9 technology) for use by SMOC on 12 November 2018. The earliest trademark right has been effective from 28 May 2015, and the domain name has been effective in 2012.
Subscribe to:
Posts (Atom)
